Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
member of a family of non-histone chromosomal proteins [RGD, Feb 2006].. Additionally we are shipping HMGN2 Kits (20) and HMGN2 Proteins (10) and many more products for this protein.
Showing 10 out of 68 products:
HMGN1 (show HMGN1 Antibodies) and HMGN2 remodel core and linker histone tail domains within chromatin.
Results provide evidence that HDAC6 (show HDAC6 Antibodies) could regulate HMGN2 acetylation levels and binding to Stat5a (show STAT5A Antibodies)-responsive promoters, and therefore, Stat5a (show STAT5A Antibodies) transcriptional activity in breast cancer cells.
elucidate a novel mechanism whereby the linker histone H1 (show H1F0 Antibodies) prevents STAT5 (show STAT5A Antibodies) binding at promoter DNA, and the PRL (show PRL Antibodies)-induced dissociation of H1 mediated by HMGN2 is necessary to allow full STAT5 (show STAT5A Antibodies) recruitment and promote the biological effects of PRL (show PRL Antibodies) signaling
Data show that high mobility group nucleosomal binding domain 2 (HMGN2) knockdown induced the increased expression of alpha5beta1 integrin on cell membranes, which resulted in a significant increase in Klebsiella pneumoniae internalization.
Data show that chronic lymphocytic leukemia (CLL) cells present high-mobility group (show SSRP1 Antibodies) nucleosome-binding protein 2 (HMGN2) at membrane.
enhanced expression of HMGN2 in osteosarcoma cells by HMGN2 lentivirus, exerts inhibitory effects on growth and migration of osteosarcoma cells.
HMGN2 is an anti-tumor effector molecule of CD8 (show CD8A Antibodies) T cells.
A polypeptide, HMGN2, was isolated and may be an antimicrobial effector molecule of mononuclear leukocytes.
HMGN2 is modified by covalent attachment of small ubiquitin-related modifier 1 (SUMO1 (show SUMO1 Antibodies)) by pro-inflammatory signal and identified the major SUMOylated lysine residues that localize to the HMGN2 nucleosome-binding domain at Lys (show LYZ Antibodies)-17 and Lys (show LYZ Antibodies)-35.
HMGN2 is a bona fide Aurora B (show AURKB Antibodies) substrate in vivo and show that its dynamic association to chromatin is controlled by Aurora B (show AURKB Antibodies).
study demonstrates a role of HMGN2 in modulating specific gene expression and identifies beta-defensin-1 (show DEFB1 Antibodies), beta-defensin-3 (show DEFB103A Antibodies), and beta-defensin-4 (show DEFB4 Antibodies) as HMGN2 targets during the development of ICR mice treated with LPS (show TLR4 Antibodies)
The ectopic expression of Hmgn2 antagonizes mouse erythroid differentiation in vitro, which may be due to enhancement of DNA replication and/or blocking entry of mitosis at S-phase.
Rate of positive nuclei in early-cleaved embryos from small-versus large-follicles is similar for HMGN2 after parthenogenesis.
member of a family of non-histone chromosomal proteins
high mobility group nucleosome-binding domain-containing protein 2
, high mobility group protein N2
, high-mobility group (nonhistone chromosomal) protein 17
, high-mobility group nucleosomal binding domain 2
, non-histone chromosomal protein HMG-17
, nonhistone chromosomal protein HMG-17
, high mobility group protein 17
, high-mobility group nucleosome-binding domain-containing protein 2
, high mobility group nucleosomal binding domain 4
, high mobility group nucleosomal binding domain 2